Regen BioPharma (RGBPP) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Regen BioPharma (RGBPP) over the last 12 years, with Q4 2025 value amounting to 27.73.
- Regen BioPharma's Equity Ratio rose 655.01% to 27.73 in Q4 2025 from the same period last year, while for Dec 2025 it was 27.73, marking a year-over-year increase of 655.01%. This contributed to the annual value of 22.87 for FY2025, which is 2938.5% up from last year.
- Regen BioPharma's Equity Ratio amounted to 27.73 in Q4 2025, which was up 655.01% from 22.87 recorded in Q3 2025.
- Over the past 5 years, Regen BioPharma's Equity Ratio peaked at 8.66 during Q2 2021, and registered a low of 121.66 during Q1 2022.
- In the last 5 years, Regen BioPharma's Equity Ratio had a median value of 25.3 in 2025 and averaged 27.07.
- In the last 5 years, Regen BioPharma's Equity Ratio skyrocketed by 9034.29% in 2021 and then plummeted by 32709.4% in 2022.
- Regen BioPharma's Equity Ratio (Quarter) stood at 13.27 in 2021, then rose by 11.1% to 11.8 in 2022, then plummeted by 178.54% to 32.86 in 2023, then grew by 9.7% to 29.67 in 2024, then rose by 6.55% to 27.73 in 2025.
- Its last three reported values are 27.73 in Q4 2025, 22.87 for Q3 2025, and 29.55 during Q2 2025.